University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Stacey Kenfield, ScD

Stacey Kenfield, ScD

Associate Professor of Urology, UCSF School of Medicine
Helen Diller Family Chair in Population Science for Urologic Cancer, UCSF

Cancer Center Program Memberships

Prostate Cancer

Education

BS, 2000, Physiological Science, UCLA, Los Angeles, CA
MS, 2003, Epidemiology, Harvard School of Public Health, Boston, MA
ScD, 2006, Epidemiology, Harvard School of Public Health, Boston, MA


Professional Experience

  • 2006-09
    Postdoctoral Research Fellow, Department of Epidemiology, Harvard School Public Health
  • 2009-12
    Research Associate, Department of Epidemiology, Harvard School Public Health
  • 2009-11
    Research Fellow, Brigham andWomen’s Hospital
  • 2011-12
    Instructor, Department of Medicine, Harvard Medical School
  • 2011-12
    Associate Epidemiologist, Brigham andWomen’s Hospital
  • 2012- present
    Visiting Scientist, Harvard School of Public Health
  • 2012- 2017
    Assistant Professor, Department of Urology, School of Medicine, UCSF
  • 2018-present
    Associate Professior, Department of Urology, School of Medicine, UCSF

Honors & Awards

  • 2003
    Harvard School of Public Health Teaching Assistant Award
  • 2003-05
    Association of Schools of Public Health and Legacy Foundation STEP-UP Award Fellowship - pre-doctoral
  • 2005-06
    NIH Research and Career Development Award in Nutritional Epidemiology of Cancer - pre-doctoral
  • 2006-09
    NIH Research and Career Development Award in Nutritional Epidemiology of Cancer andCancer Epidemiology - post-doctoral
  • 2008
    American Association for Cancer Research Minority Scholar in Cancer Research Award
  • 2012
    Michael Milken Prostate Cancer Foundation Young Investigator Award

Selected Publications

  1. Zuniga KB, Borno H, Chan JM, Van Blarigan EL, Friedlander TW, Wang S, Zhang L, Kenfield SA. The Problem of Underrepresentation: Black Participants in Lifestyle Trials Among Patients with Prostate Cancer. J Racial Ethn Health Disparities. 2020 Feb 20.
    View on PubMed
  2. Van Blarigan EL, Kenfield SA, Chan JM, Van Loon K, Paciorek A, Zhang L, Chan H, Savoie MB, Bocobo AG, Liu VN, Wong LX, Laffan A, Atreya CE, Miaskowski C, Fukuoka Y, Meyerhardt JA, Venook AP. Feasibility and Acceptability of a Web-Based Dietary Intervention with Text Messages for Colorectal Cancer: A Randomized Pilot Trial. Cancer Epidemiol Biomarkers Prev. 2020 Apr; 29(4):752-760.
    View on PubMed
  3. Narayan V, Harrison M, Cheng H, Kenfield S, Aggarwal R, Kwon D, McKay R, Hauger R, Hart N, Conzen S, Borno H, Jim H, Dicker A, Dorff T, Moslehi J, Mucci L, Parsons JK, Saad F, Soule H, Morgans A, Ryan CJ. Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group. Urol Oncol. 2020 Mar; 38(3):83-93.
    View on PubMed
  4. Belkora J, Chan JM, Cooperberg MR, Neuhaus J, Stupar L, Weinberg T, Broering JM, Tenggara I, Cowan JE, Rosenfeld S, Kenfield SA, Van Blarigan EL, Simko JP, Witte J, Carroll PR. Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patients. Cancer Med. 2020 01; 9(1):125-132.
    View on PubMed
  5. Zuniga KB, Zhao S, Kenfield SA, Cedars B, Cowan JE, Van Blarigan EL, Broering JM, Carroll PR, Chan JM. Trends in Complementary and Alternative Medicine Use among Patients with Prostate Cancer. J Urol. 2019 10; 202(4):689-695.
    View on PubMed
  6. Langlais CS, Cowan JE, Neuhaus J, Kenfield SA, Van Blarigan EL, Broering JM, Cooperberg MR, Carroll P, Chan JM. Obesity at Diagnosis and Prostate Cancer Prognosis and Recurrence Risk Following Primary Treatment by Radical Prostatectomy. Cancer Epidemiol Biomarkers Prev. 2019 11; 28(11):1917-1925.
    View on PubMed
  7. Zuniga KB, Chan JM, Ryan CJ, Kenfield SA. Diet and lifestyle considerations for patients with prostate cancer. Urol Oncol. 2020 Mar; 38(3):105-117.
    View on PubMed
  8. Downer MK, Kenfield SA, Stampfer MJ, Wilson KM, Dickerman BA, Giovannucci EL, Rimm EB, Wang M, Mucci LA, Willett WC, Chan JM, Van Blarigan EL. Alcohol Intake and Risk of Lethal Prostate Cancer in the Health Professionals Follow-Up Study. J Clin Oncol. 2019 06 10; 37(17):1499-1511.
    View on PubMed
  9. Van Blarigan EL, Chan H, Van Loon K, Kenfield SA, Chan JM, Mitchell E, Zhang L, Paciorek A, Joseph G, Laffan A, Atreya CE, Fukuoka Y, Miaskowski C, Meyerhardt JA, Venook AP. Self-monitoring and reminder text messages to increase physical activity in colorectal cancer survivors (Smart Pace): a pilot randomized controlled trial. BMC Cancer. 2019 Mar 11; 19(1):218.
    View on PubMed
  10. Kenfield SA, Van Blarigan EL, Ameli N, Lavaki E, Cedars B, Paciorek AT, Monroy C, Tantum LK, Newton RU, Signorell C, Suh JH, Zhang L, Cooperberg MR, Carroll PR, Chan JM. Feasibility, Acceptability, and Behavioral Outcomes from a Technology-enhanced Behavioral Change Intervention (Prostate 8): A Pilot Randomized Controlled Trial in Men with Prostate Cancer. Eur Urol. 2019 06; 75(6):950-958.
    View on PubMed
  11. Winters-Stone KM, Kenfield SA, Van Blarigan EL, Moe EL, Ramsdill JW, Daniel K, Macaire G, Paich K, Kessler ER, Kucuk O, Gillespie TW, Lyons KS, Beer TM, Broering JM, Carroll PR, Chan JM. Effect of Increasing Levels of Web-Based Behavioral Support on Changes in Physical Activity, Diet, and Symptoms in Men With Prostate Cancer: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2018 Nov 15; 7(11):e11257.
    View on PubMed
  12. Downer MK, Allard CB, Preston MA, Wilson KM, Kenfield SA, Chan JM, Mucci LA, Giovannucci E, Stampfer MJ. Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up Study. Eur Urol Oncol. 2019 03; 2(2):126-134.
    View on PubMed
  13. Chan JM, Kenfield SA, Platz EA. Association of Statin Use With Overall and Cancer Survival. JAMA Oncol. 2018 07 01; 4(7):1016.
    View on PubMed
  14. Newton RU, Kenfield SA, Hart NH, Chan JM, Courneya KS, Catto J, Finn SP, Greenwood R, Hughes DC, Mucci L, Plymate SR, Praet SFE, Guinan EM, Van Blarigan EL, Casey O, Buzza M, Gledhill S, Zhang L, Galvão DA, Ryan CJ, Saad F. Intense Exercise for Survival among Men with Metastatic Castrate-Resistant Prostate Cancer (INTERVAL-GAP4): a multicentre, randomised, controlled phase III study protocol. BMJ Open. 2018 05 14; 8(5):e022899.
    View on PubMed
  15. Bauer SR, Van Blarigan EL, Stampfer MJ, Chan JM, Kenfield SA. Mediterranean diet after prostate cancer diagnosis and urinary and sexual functioning: The health professionals follow-up study. Prostate. 2018 02; 78(3):202-212.
    View on PubMed
  16. Joshu CE, Peskoe SB, Heaphy CM, Kenfield SA, Mucci LA, Giovannucci EL, Stampfer MJ, Yoon G, Lee TK, Hicks JL, De Marzo AM, Meeker AK, Platz EA. Current or recent smoking is associated with more variable telomere length in prostate stromal cells and prostate cancer cells. Prostate. 2018 02; 78(3):233-238.
    View on PubMed
  17. Tat D, Kenfield SA, Cowan JE, Broering JM, Carroll PR, Van Blarigan EL, Chan JM. Milk and other dairy foods in relation to prostate cancer recurrence: Data from the cancer of the prostate strategic urologic research endeavor (CaPSURE™). Prostate. 2018 Jan; 78(1):32-39.
    View on PubMed
  18. Van Blarigan EL, Kenfield SA, Tantum L, Cadmus-Bertram LA, Carroll PR, Chan JM. The Fitbit One Physical Activity Tracker in Men With Prostate Cancer: Validation Study. JMIR Cancer. 2017 Apr 18; 3(1):e5.
    View on PubMed
  19. Thomas RJ, Kenfield SA, Jimenez A. Exercise-induced biochemical changes and their potential influence on cancer: a scientific review. Br J Sports Med. 2017 Apr; 51(8):640-644.
    View on PubMed
  20. Peisch SF, Van Blarigan EL, Chan JM, Stampfer MJ, Kenfield SA. Prostate cancer progression and mortality: a review of diet and lifestyle factors. World J Urol. 2017 Jun; 35(6):867-874.
    View on PubMed

Go to UCSF Profiles, powered by CTSI